Publicaciones en colaboración con investigadores/as de Universidade da Coruña (28)

2024

  1. Therapeutic management of CNIC polypill at discharge from a first acute coronary syndrome in Spain: The PANDORA study

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 266-277

2021

  1. Economic evaluation of complete revascularization versus stress echocardiography-guided revascularization in the STEACS with multivessel disease

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1055-1062

2020

  1. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1424-1437

  2. Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 652-659

  3. Pulmonary Arteriovenous Malformation and Embolic Myocardial Infarction in a Patient With Hereditary Hemorrhagic Telangiectasia

    JACC: Case Reports, Vol. 2, Núm. 2, pp. 316-318

  4. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 1, pp. 92-102

  5. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1378-1389

2019

  1. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1338-1352

  2. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

2018

  1. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462

2017

  1. Prognostic Value of the Nutritional Risk Index in Heart Transplant Recipients

    Revista Espanola de Cardiologia, Vol. 70, Núm. 8, pp. 639-645

2016

  1. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report

    Cardiology Journal, Vol. 23, Núm. 5, pp. 573-582

  2. Estado serológico frente a Toxoplasma gondii en receptores de trasplante cardiaco: ¿un factor pronóstico independiente?

    Revista Espanola de Cardiologia, Vol. 69, Núm. 12, pp. 1160-1166

2015

  1. Clinical characteristics and long-term outcomes of patients undergoing combined heart-kidney transplantation: A single-center experience

    Transplantation Proceedings

  2. Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: Short-term and long-term efficacy and safety results

    Transplant International, Vol. 28, Núm. 9, pp. 1034-1041

  3. First report of the Spanish Post-Heart-Transplant Tumor Registry

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 50-57

  4. Significado pronóstico y evolución a largo plazo de la frecuencia cardiaca en los pacientes con trasplante cardiaco

    Revista Espanola de Cardiologia, Vol. 68, Núm. 11, pp. 943-950

  5. Venous thromboembolism in heart transplant recipients: Incidence, recurrence and predisposing factors

    Journal of Heart and Lung Transplantation, Vol. 34, Núm. 2, pp. 167-174

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

2012

  1. Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: Effect of preemptive therapy

    Transplantation Proceedings